PTX3 and central nervous system cancer: Previous studies have identified several molecular markers associated with glioma (Michaëlsson et al., 2023; Žugec et al., 2024); however, the specific roles and mechanisms of Pentraxin 3 (PTX3) remain inadequately explored, highlighting a significant gap in the current research.